2Campbell RK.Glimepiride:role of a new sulfonylurea in the treatment of type 2 diabetes mellitus[J],1998(10).
3Goldberg RB;Schneider J;Holvey SM.A dose-response study of glimpiride in patients with NIDDM who have previously received sulfonylurea agents[J],1996.
7Haffner SM,D,Agostino R,Mykkanen L.Insulin sensitivity in subject with type 2 diabetes.Diabetes Care,1999,22:256-268.
8Muller G,Hartz D,Punter J.et al.Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor I binding chatacteristics.Biochim Biophys Acta,1994,1191:267-277.
9Kobayashi M,Kaku K,Kawamori R,et al.Glimepiride improves HbAlc without weight gain in obese Japanese type 2 diabetic patients.Diabetes,2003,52(1):A97.
10Martin S,Scherbaum WA,Kolb W.Analysis of the impact of oral anti-diabetic drugs on development of body weight by a retrolective trial,a new form of non-biased retrospective clinical study design.Diabetes,2002,51(2):A107.Abstract 433.
